Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
J.D. Maclean, S. Mahanty.
Liver, lung, and intestinal fluke intections.
Tropical Infectious Diseases: Principles, Pathogens and Practice 1st ed, pp. 1039
[2.]
C.W. Chan, S.K. Lam.
Diseases caused by liver flukes and cholangiocarcinoma.
Baillieres Clin Gastroenterol, 1 (1987), pp. 297
[3.]
R. Arjona, J.A. Riancho, J.M. Aguado.
Fasciolasis in developed countries: a review of classic and aberrant forms of the disease.
Medicine (Baltimore), 74 (1995), pp. 13
[4.]
A. Cosme, E. Ojeda, G. Cilla, J. Torrado, L. Alzate.
Fasciolasis hepatobiliar. Estudio de una serie de 37 pacientes.
Gastroenterol Hepatol, 24 (2001), pp. 375-380
[5.]
M. Alban Olaya, J. Jave Ortiz, T. Quiste Lazo.
Fasciolasis in cajamarca.
Rev Gastroenterol Perú, 28 (2002), pp. 32
[6.]
G.V. Hillyer, D.E. Soler, M. Galanes, J. Rodríguez-Pérez.
Use of the Falcon assay screening test-enzyme-linked immunosorbent assa (FAST ELISA) and the enzyme-linked immunoelectrotransfer blot (EITB) to determine the prevalence of human fasciolasis in the Bolivian Altiplano.
Am J Trop Med Hyg, 46 (1992), pp. 603
[7.]
A.M. Espino, C.M. Finlay.
Sandwich enzyme-linked immunosorbent assay for detection of excretory secretory antigens in humans with fasciolasis (published erratum appears in J Clin Microbiol 1994 Mar;32(3):860).
J Clin Microbiol, 32 (1994), pp. 190
[8.]
W.A. Mansour, M.A. Kaddah, Z.A. Shaker.
A monoclonal antobody diagnoses active Fasciola infection in humans.
J Egypt Soc Parasitol, 28 (1998), pp. 711
[9.]
H.I. Shaheen, K.A. Kamal, Z. Farid.
Dot-enzyme-linked immunosorbent assay (dot-ELISA) for the rapid diagnosis of human fasciolasis.
J Parasitol, 75 (1989), pp. 549
[10.]
A.Y. Shehab, E.M. Hassan, L.M. Basha.
Detection of circulating E/S antigens in the sera of patients with fasciolasis by IELISA: a tool of serodiagnosis and assessment of cure.
Trop Med Int Health, 4 (1999), pp. 686
[11.]
N.A. Hammouda, S.T. el Mansoury, M.Z. el Azzouni, E.D. Hussein.
Detection of circulating antigens in blood to evaluate treatment of fasciolasis.
J Egypt Soc Parasitol, 27 (1997), pp. 365
[12.]
N. Santiago, G.V. Hillyer.
Antibody profiles by EITB and ELISA of cattle and sheep infected with Fasciola hepatica.
J Parasitol, 74 (1988), pp. 810
[13.]
B. Van Beers, J. Pringot, A. Geubel.
Hepatobiliary fasciolasis: noninvasive imaging findings.
Radiology, 174 (1990), pp. 809
[14.]
L.M. Dias, R. Silva, H.L. Viana.
Biliary fasciolasis: diagnosis, treatment and follow-up by ERCP.
Gastrointest Endosc, 43 (1996), pp. 616
[15.]
H. El-Karaksy, B. Hassanein, S. Okasha.
Human fascioliasis in Egyptian children successful treatment with triclabendazole.
J Trop Pediatr, 45 (1999), pp. 135
[16.]
Farg, Hf, Salem, A, el-Hifni, Sa, Kandil.
M. Bithionol (Bitin) treatment in established fascioliasis in Egyptians.
J Trop Med Hyg, 91 (1988), pp. 240
[17.]
J.F. Rossignol, H. Abaza, H. Friedman.
Successful treatment of human fascioliasis with nitazoxanide.
Trans R Soc Trop Med Hyg, 92 (1998), pp. 103
Copyright © 2003. Elsevier España, S.L. y Sociedad Española de Medicina Rural y Generalista (SEMERGEN)
